Background/Aims: Transjugular intrahepatic portosystemic shunt (TIPS) is a technically
challenging but feasible treatment for Budd–Chiari syndrome (BCS). However, information about …

In real-world clinical practice, the acceptance of anticoagulation therapy in the management
of portal vein thrombosis (PVT) in patients with cirrhosis is limited by the fear of an increased …

Aims and Background Cisplatin, a standard component of combination chemotherapy for
several tumors, presents important anti-tumor properties but also several toxic effects. In …

We conducted a large, multicenter, retrospective survey aimed to explore the impact of tumor
bone involvement in Non-Small Cell Lung Cancer. Data on clinical-pathology, skeletal …

Pancreatic cancer is a common, highly lethal disease with a rising incidence. In the last
years continued efforts in pancreatic cancer research have led to a change in the classic …

BACKGROUND: Several methods have been reported to minimize patient discomfort during
colonoscopy, none are currently recommended by clinical practice guidelines. We …

Hepatocellular carcinoma (HCC) is a complication of cirrhosis. Due to blood transfusions,
patients with β-thalassemia (thal) are often infected with either hepatitis C virus (HCV) or …

Due to blood transfusions, thalassemics are often infected with either hepatitis C virus (HCV)
or hepatitis B virus and often have hemochromatosis. Hepatocellular carcinoma (HCC) has …

BACKGROUND: Patients with small-cell lung cancer (SCLC) that progress after first-line
chemotherapy have a poor prognosis and the evidence of a benefit from second-line (SL) …

Aims The aim of this study was to assess the safety and efficacy of sorafenib, with or without
everolimus, in the treatment of recurrent hepatocellular carcinoma (HCC) after an orthotopic …